Ixico Plc IXI
Dividend Summary
There have not been any declared dividends recently.
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | – | – |
| Type | – | – |
| Per share | – | – |
| Declaration date | – | – |
| Ex-div date | – | – |
| Pay date | – | – |
Enter the number of Ixico Plc shares you hold and we'll calculate your dividend payments:
Sign up for Ixico Plc and we'll email you the dividend information when they declare.
Add Ixico Plc to receive free notifications when they declare their dividends.
Your account is set up to receive Ixico Plc notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| There are no Ixico Plc dividends. | ||||||||
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0p | — |
| 2007 | 0.0p | 0% |
| 2008 | 0.0p | 0% |
| 2009 | 0.0p | 0% |
| 2010 | 0.0p | 0% |
| 2011 | 0.0p | 0% |
| 2012 | 0.0p | 0% |
| 2013 | 0.0p | 0% |
| 2014 | 0.0p | 0% |
| 2015 | 0.0p | 0% |
| 2016 | 0.0p | 0% |
| 2017 | 0.0p | 0% |
| 2018 | 0.0p | 0% |
| 2019 | 0.0p | 0% |
| 2020 | 0.0p | 0% |
| 2021 | 0.0p | 0% |
| 2022 | 0.0p | 0% |
| 2023 | 0.0p | 0% |
| 2024 | Sign Up Required | |
Ixico Plc Optimized Dividend Chart
- Dividend Yield Today
- 0.0%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 0.0% on 21 April 2023
- 52 Week Low
- 0.0% on 21 April 2023
- Next Ex-Div-Date Countdown
- Sign Up Required
About Ixico Plc
IXICO plc is primarily engaged in artificial intelligence (AI) data analytics company that delivers insights into neuroscience. The Company’s data analytics services are used by the global biopharmaceutical industry to interpret data from brain scans and digital biosensors to enable trial design, site qualification, patient selection and clinical outcomes. It provides technology-enabled services across all phases of clinical evaluation. The Company’s services include the collection, analysis, management and reporting of data generated during a clinical study and the outputs from the data analysis. The Company’s integrated digital platform provides a scalable and secure infrastructure for the capture and analysis of regulatory compliant clinical data to enable clients to make better-informed decisions. Its geographical area includes Switzerland, United Kingdom, United States of America, Netherlands, Ireland and Europe.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- United Kingdom
- Share Price
- £0.09 (yesterday's closing price)
- Shares in Issue
- 48 million
- Market Cap
- £4mn
- 0
- Market Indices
- none
